Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biofrontera (BFRI) Short term Debt: 2021-2023

Historic Short term Debt for Biofrontera (BFRI) over the last 3 years, with Dec 2023 value amounting to $3.9 million.

  • Biofrontera's Short term Debt was N/A to $296,000 in Q2 2024 from the same period last year, while for Jun 2024 it was $296,000, marking a year-over-year change of. This contributed to the annual value of $3.9 million for FY2023, which is 43.76% down from last year.
  • Latest data reveals that Biofrontera reported Short term Debt of $3.9 million as of FY2023, which was down 43.76% from $6.9 million recorded in FY2022.
  • Over the past 5 years, Biofrontera's Short term Debt peaked at $6.9 million during FY2022, and registered a low of $3.2 million during FY2021.
  • Over the past 3 years, Biofrontera's median Short term Debt value was $3.9 million (recorded in 2023), while the average stood at $4.7 million.
  • In the last 5 years, Biofrontera's Short term Debt spiked by 114.13% in 2022 and then slumped by 43.76% in 2023.
  • Yearly analysis of 3 years shows Biofrontera's Short term Debt stood at $3.2 million in 2021, then skyrocketed by 114.13% to $6.9 million in 2022, then plummeted by 43.76% to $3.9 million in 2023.